Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2

In healthy adults, activation of γ-aminobutyric acid (GABA) A and glycine receptors inhibits neurons as a result of low intracellular chloride concentration ([Cl –] ᵢ), which is maintained by the potassium-chloride cotransporter KCC2. A reduction of KCC2 expression or function is implicated in the p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 2013-01, Vol.110 (1), p.348-353
Hauptverfasser: Bos, Rémi, Sadlaoud, Karina, Boulenguez, Pascale, Buttigieg, Dorothée, Liabeuf, Sylvie, Brocard, Cécile, Haase, Georg, Bras, Hélène, Vinay, Laurent
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 353
container_issue 1
container_start_page 348
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 110
creator Bos, Rémi
Sadlaoud, Karina
Boulenguez, Pascale
Buttigieg, Dorothée
Liabeuf, Sylvie
Brocard, Cécile
Haase, Georg
Bras, Hélène
Vinay, Laurent
description In healthy adults, activation of γ-aminobutyric acid (GABA) A and glycine receptors inhibits neurons as a result of low intracellular chloride concentration ([Cl –] ᵢ), which is maintained by the potassium-chloride cotransporter KCC2. A reduction of KCC2 expression or function is implicated in the pathogenesis of several neurological disorders, including spasticity and chronic pain following spinal cord injury (SCI). Given the critical role of KCC2 in regulating the strength and robustness of inhibition, identifying tools that may increase KCC2 function and, hence, restore endogenous inhibition in pathological conditions is of particular importance. We show that activation of 5-hydroxytryptamine (5-HT) type 2A receptors to serotonin hyperpolarizes the reversal potential of inhibitory postsynaptic potentials (IPSPs), E IPSP, in spinal motoneurons, increases the cell membrane expression of KCC2 and both restores endogenous inhibition and reduces spasticity after SCI in rats. Up-regulation of KCC2 function by targeting 5-HT ₂A receptors, therefore, has therapeutic potential in the treatment of neurological disorders involving altered chloride homeostasis. However, these receptors have been implicated in several psychiatric disorders, and their effects on pain processing are controversial, highlighting the need to further investigate the potential systemic effects of specific 5-HT ₂AR agonists, such as (4-bromo-3,6-dimethoxybenzocyclobuten-1-yl)methylamine hydrobromide (TCB-2).
doi_str_mv 10.1073/pnas.1213680110
format Article
fullrecord <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmed_primary_23248270</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>42553943</jstor_id><sourcerecordid>42553943</sourcerecordid><originalsourceid>FETCH-LOGICAL-c622t-8a6be781e506c6a752150eb8472deda9dfddd96cfa6b75a0df121edd09d9e8553</originalsourceid><addsrcrecordid>eNpdkc1vEzEQxS0EomnhzAlYiQscth1_ey9IUVQIaiQOtGfLsb3JRpv1Yu9G4r_Hq6Qp9GTZ7zfPM_MQeofhGoOkN31n0jUmmAoFGMMLNMNQ4VKwCl6iGQCRpWKEXaDLlHYAUHEFr9EFoYQpImGG9NwOzcEMTeiKUBe8XN6TeRG99f0QYirGPvrN2JrBp2LY-qIeO_sIT_fOjzF0pi3uykVb2DBE06U-xMHH4m6xIG_Qq9q0yb89nVfo4dvt_WJZrn5-_7GYr0orCBlKZcTaS4U9B2GFkZxgDn6tmCTOO1O52jlXCVtnTnIDrs5De-egcpVXnNMr9PXo24_rvXfWd7mTVvex2Zv4RwfT6P-VrtnqTThoyqnC1WTw5WiwfVa2nK_09AYkr49yccCZ_Xz6LIbfo0-D3jfJ-rY1nQ9j0lgBxSCohIx-eobuwhjzwjJFhGCUgWSZujlSNoaUoq_PHWDQU9B6Clo_BZ0rPvw775l_TDYD70_AVHm2m_w0ZepJ36Uc9BlgJC-zYjTrH496bYI2m9gk_fCLABYAOG9MCvoX3gjAMw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1266434074</pqid></control><display><type>article</type><title>Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Bos, Rémi ; Sadlaoud, Karina ; Boulenguez, Pascale ; Buttigieg, Dorothée ; Liabeuf, Sylvie ; Brocard, Cécile ; Haase, Georg ; Bras, Hélène ; Vinay, Laurent</creator><creatorcontrib>Bos, Rémi ; Sadlaoud, Karina ; Boulenguez, Pascale ; Buttigieg, Dorothée ; Liabeuf, Sylvie ; Brocard, Cécile ; Haase, Georg ; Bras, Hélène ; Vinay, Laurent</creatorcontrib><description>In healthy adults, activation of γ-aminobutyric acid (GABA) A and glycine receptors inhibits neurons as a result of low intracellular chloride concentration ([Cl –] ᵢ), which is maintained by the potassium-chloride cotransporter KCC2. A reduction of KCC2 expression or function is implicated in the pathogenesis of several neurological disorders, including spasticity and chronic pain following spinal cord injury (SCI). Given the critical role of KCC2 in regulating the strength and robustness of inhibition, identifying tools that may increase KCC2 function and, hence, restore endogenous inhibition in pathological conditions is of particular importance. We show that activation of 5-hydroxytryptamine (5-HT) type 2A receptors to serotonin hyperpolarizes the reversal potential of inhibitory postsynaptic potentials (IPSPs), E IPSP, in spinal motoneurons, increases the cell membrane expression of KCC2 and both restores endogenous inhibition and reduces spasticity after SCI in rats. Up-regulation of KCC2 function by targeting 5-HT ₂A receptors, therefore, has therapeutic potential in the treatment of neurological disorders involving altered chloride homeostasis. However, these receptors have been implicated in several psychiatric disorders, and their effects on pain processing are controversial, highlighting the need to further investigate the potential systemic effects of specific 5-HT ₂AR agonists, such as (4-bromo-3,6-dimethoxybenzocyclobuten-1-yl)methylamine hydrobromide (TCB-2).</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.1213680110</identifier><identifier>PMID: 23248270</identifier><language>eng</language><publisher>United States: National Academy of Sciences</publisher><subject>adults ; agonists ; animal injuries ; Animals ; behavior disorders ; Behavioral neuroscience ; Biological Sciences ; Blotting, Western ; Bridged Bicyclo Compounds - pharmacology ; Cell membranes ; Chlorides ; Chlorides - metabolism ; gamma-aminobutyric acid ; Gene expression ; Gene Expression Regulation - drug effects ; H-Reflex ; Homeostasis ; Immunohistochemistry ; Inhibitory Postsynaptic Potentials - physiology ; K Cl- Cotransporters ; Life Sciences ; methylamine ; Methylamines - pharmacology ; motor neurons ; Motor Neurons - metabolism ; Muscle Spasticity - drug therapy ; Muscle Spasticity - etiology ; nervous system diseases ; Neurobiology ; Neurochemistry ; Neurological disorders ; Neurons ; Neurons and Cognition ; Pain ; pathogenesis ; Pathology ; potassium chloride ; Proteins ; Rats ; Receptor, Serotonin, 5-HT2A - metabolism ; Receptors ; Serotonin ; Serotonin - metabolism ; Serotonin - pharmacology ; Serotonin 5-HT2 Receptor Agonists - pharmacology ; Serotonin receptors ; Spinal cord ; Spinal Cord Injuries - complications ; Spinal Nerve roots ; symporters ; Symporters - metabolism</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2013-01, Vol.110 (1), p.348-353</ispartof><rights>copyright © 1993-2008 National Academy of Sciences of the United States of America</rights><rights>Copyright National Academy of Sciences Jan 2, 2013</rights><rights>Attribution</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c622t-8a6be781e506c6a752150eb8472deda9dfddd96cfa6b75a0df121edd09d9e8553</citedby><cites>FETCH-LOGICAL-c622t-8a6be781e506c6a752150eb8472deda9dfddd96cfa6b75a0df121edd09d9e8553</cites><orcidid>0000-0001-5384-9006 ; 0000-0003-2639-3271</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/110/1.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/42553943$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/42553943$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,723,776,780,799,881,27901,27902,53766,53768,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23248270$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://amu.hal.science/hal-02009356$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Bos, Rémi</creatorcontrib><creatorcontrib>Sadlaoud, Karina</creatorcontrib><creatorcontrib>Boulenguez, Pascale</creatorcontrib><creatorcontrib>Buttigieg, Dorothée</creatorcontrib><creatorcontrib>Liabeuf, Sylvie</creatorcontrib><creatorcontrib>Brocard, Cécile</creatorcontrib><creatorcontrib>Haase, Georg</creatorcontrib><creatorcontrib>Bras, Hélène</creatorcontrib><creatorcontrib>Vinay, Laurent</creatorcontrib><title>Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>In healthy adults, activation of γ-aminobutyric acid (GABA) A and glycine receptors inhibits neurons as a result of low intracellular chloride concentration ([Cl –] ᵢ), which is maintained by the potassium-chloride cotransporter KCC2. A reduction of KCC2 expression or function is implicated in the pathogenesis of several neurological disorders, including spasticity and chronic pain following spinal cord injury (SCI). Given the critical role of KCC2 in regulating the strength and robustness of inhibition, identifying tools that may increase KCC2 function and, hence, restore endogenous inhibition in pathological conditions is of particular importance. We show that activation of 5-hydroxytryptamine (5-HT) type 2A receptors to serotonin hyperpolarizes the reversal potential of inhibitory postsynaptic potentials (IPSPs), E IPSP, in spinal motoneurons, increases the cell membrane expression of KCC2 and both restores endogenous inhibition and reduces spasticity after SCI in rats. Up-regulation of KCC2 function by targeting 5-HT ₂A receptors, therefore, has therapeutic potential in the treatment of neurological disorders involving altered chloride homeostasis. However, these receptors have been implicated in several psychiatric disorders, and their effects on pain processing are controversial, highlighting the need to further investigate the potential systemic effects of specific 5-HT ₂AR agonists, such as (4-bromo-3,6-dimethoxybenzocyclobuten-1-yl)methylamine hydrobromide (TCB-2).</description><subject>adults</subject><subject>agonists</subject><subject>animal injuries</subject><subject>Animals</subject><subject>behavior disorders</subject><subject>Behavioral neuroscience</subject><subject>Biological Sciences</subject><subject>Blotting, Western</subject><subject>Bridged Bicyclo Compounds - pharmacology</subject><subject>Cell membranes</subject><subject>Chlorides</subject><subject>Chlorides - metabolism</subject><subject>gamma-aminobutyric acid</subject><subject>Gene expression</subject><subject>Gene Expression Regulation - drug effects</subject><subject>H-Reflex</subject><subject>Homeostasis</subject><subject>Immunohistochemistry</subject><subject>Inhibitory Postsynaptic Potentials - physiology</subject><subject>K Cl- Cotransporters</subject><subject>Life Sciences</subject><subject>methylamine</subject><subject>Methylamines - pharmacology</subject><subject>motor neurons</subject><subject>Motor Neurons - metabolism</subject><subject>Muscle Spasticity - drug therapy</subject><subject>Muscle Spasticity - etiology</subject><subject>nervous system diseases</subject><subject>Neurobiology</subject><subject>Neurochemistry</subject><subject>Neurological disorders</subject><subject>Neurons</subject><subject>Neurons and Cognition</subject><subject>Pain</subject><subject>pathogenesis</subject><subject>Pathology</subject><subject>potassium chloride</subject><subject>Proteins</subject><subject>Rats</subject><subject>Receptor, Serotonin, 5-HT2A - metabolism</subject><subject>Receptors</subject><subject>Serotonin</subject><subject>Serotonin - metabolism</subject><subject>Serotonin - pharmacology</subject><subject>Serotonin 5-HT2 Receptor Agonists - pharmacology</subject><subject>Serotonin receptors</subject><subject>Spinal cord</subject><subject>Spinal Cord Injuries - complications</subject><subject>Spinal Nerve roots</subject><subject>symporters</subject><subject>Symporters - metabolism</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc1vEzEQxS0EomnhzAlYiQscth1_ey9IUVQIaiQOtGfLsb3JRpv1Yu9G4r_Hq6Qp9GTZ7zfPM_MQeofhGoOkN31n0jUmmAoFGMMLNMNQ4VKwCl6iGQCRpWKEXaDLlHYAUHEFr9EFoYQpImGG9NwOzcEMTeiKUBe8XN6TeRG99f0QYirGPvrN2JrBp2LY-qIeO_sIT_fOjzF0pi3uykVb2DBE06U-xMHH4m6xIG_Qq9q0yb89nVfo4dvt_WJZrn5-_7GYr0orCBlKZcTaS4U9B2GFkZxgDn6tmCTOO1O52jlXCVtnTnIDrs5De-egcpVXnNMr9PXo24_rvXfWd7mTVvex2Zv4RwfT6P-VrtnqTThoyqnC1WTw5WiwfVa2nK_09AYkr49yccCZ_Xz6LIbfo0-D3jfJ-rY1nQ9j0lgBxSCohIx-eobuwhjzwjJFhGCUgWSZujlSNoaUoq_PHWDQU9B6Clo_BZ0rPvw775l_TDYD70_AVHm2m_w0ZepJ36Uc9BlgJC-zYjTrH496bYI2m9gk_fCLABYAOG9MCvoX3gjAMw</recordid><startdate>20130102</startdate><enddate>20130102</enddate><creator>Bos, Rémi</creator><creator>Sadlaoud, Karina</creator><creator>Boulenguez, Pascale</creator><creator>Buttigieg, Dorothée</creator><creator>Liabeuf, Sylvie</creator><creator>Brocard, Cécile</creator><creator>Haase, Georg</creator><creator>Bras, Hélène</creator><creator>Vinay, Laurent</creator><general>National Academy of Sciences</general><general>National Acad Sciences</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7S9</scope><scope>L.6</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5384-9006</orcidid><orcidid>https://orcid.org/0000-0003-2639-3271</orcidid></search><sort><creationdate>20130102</creationdate><title>Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2</title><author>Bos, Rémi ; Sadlaoud, Karina ; Boulenguez, Pascale ; Buttigieg, Dorothée ; Liabeuf, Sylvie ; Brocard, Cécile ; Haase, Georg ; Bras, Hélène ; Vinay, Laurent</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c622t-8a6be781e506c6a752150eb8472deda9dfddd96cfa6b75a0df121edd09d9e8553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>adults</topic><topic>agonists</topic><topic>animal injuries</topic><topic>Animals</topic><topic>behavior disorders</topic><topic>Behavioral neuroscience</topic><topic>Biological Sciences</topic><topic>Blotting, Western</topic><topic>Bridged Bicyclo Compounds - pharmacology</topic><topic>Cell membranes</topic><topic>Chlorides</topic><topic>Chlorides - metabolism</topic><topic>gamma-aminobutyric acid</topic><topic>Gene expression</topic><topic>Gene Expression Regulation - drug effects</topic><topic>H-Reflex</topic><topic>Homeostasis</topic><topic>Immunohistochemistry</topic><topic>Inhibitory Postsynaptic Potentials - physiology</topic><topic>K Cl- Cotransporters</topic><topic>Life Sciences</topic><topic>methylamine</topic><topic>Methylamines - pharmacology</topic><topic>motor neurons</topic><topic>Motor Neurons - metabolism</topic><topic>Muscle Spasticity - drug therapy</topic><topic>Muscle Spasticity - etiology</topic><topic>nervous system diseases</topic><topic>Neurobiology</topic><topic>Neurochemistry</topic><topic>Neurological disorders</topic><topic>Neurons</topic><topic>Neurons and Cognition</topic><topic>Pain</topic><topic>pathogenesis</topic><topic>Pathology</topic><topic>potassium chloride</topic><topic>Proteins</topic><topic>Rats</topic><topic>Receptor, Serotonin, 5-HT2A - metabolism</topic><topic>Receptors</topic><topic>Serotonin</topic><topic>Serotonin - metabolism</topic><topic>Serotonin - pharmacology</topic><topic>Serotonin 5-HT2 Receptor Agonists - pharmacology</topic><topic>Serotonin receptors</topic><topic>Spinal cord</topic><topic>Spinal Cord Injuries - complications</topic><topic>Spinal Nerve roots</topic><topic>symporters</topic><topic>Symporters - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bos, Rémi</creatorcontrib><creatorcontrib>Sadlaoud, Karina</creatorcontrib><creatorcontrib>Boulenguez, Pascale</creatorcontrib><creatorcontrib>Buttigieg, Dorothée</creatorcontrib><creatorcontrib>Liabeuf, Sylvie</creatorcontrib><creatorcontrib>Brocard, Cécile</creatorcontrib><creatorcontrib>Haase, Georg</creatorcontrib><creatorcontrib>Bras, Hélène</creatorcontrib><creatorcontrib>Vinay, Laurent</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bos, Rémi</au><au>Sadlaoud, Karina</au><au>Boulenguez, Pascale</au><au>Buttigieg, Dorothée</au><au>Liabeuf, Sylvie</au><au>Brocard, Cécile</au><au>Haase, Georg</au><au>Bras, Hélène</au><au>Vinay, Laurent</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>2013-01-02</date><risdate>2013</risdate><volume>110</volume><issue>1</issue><spage>348</spage><epage>353</epage><pages>348-353</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>In healthy adults, activation of γ-aminobutyric acid (GABA) A and glycine receptors inhibits neurons as a result of low intracellular chloride concentration ([Cl –] ᵢ), which is maintained by the potassium-chloride cotransporter KCC2. A reduction of KCC2 expression or function is implicated in the pathogenesis of several neurological disorders, including spasticity and chronic pain following spinal cord injury (SCI). Given the critical role of KCC2 in regulating the strength and robustness of inhibition, identifying tools that may increase KCC2 function and, hence, restore endogenous inhibition in pathological conditions is of particular importance. We show that activation of 5-hydroxytryptamine (5-HT) type 2A receptors to serotonin hyperpolarizes the reversal potential of inhibitory postsynaptic potentials (IPSPs), E IPSP, in spinal motoneurons, increases the cell membrane expression of KCC2 and both restores endogenous inhibition and reduces spasticity after SCI in rats. Up-regulation of KCC2 function by targeting 5-HT ₂A receptors, therefore, has therapeutic potential in the treatment of neurological disorders involving altered chloride homeostasis. However, these receptors have been implicated in several psychiatric disorders, and their effects on pain processing are controversial, highlighting the need to further investigate the potential systemic effects of specific 5-HT ₂AR agonists, such as (4-bromo-3,6-dimethoxybenzocyclobuten-1-yl)methylamine hydrobromide (TCB-2).</abstract><cop>United States</cop><pub>National Academy of Sciences</pub><pmid>23248270</pmid><doi>10.1073/pnas.1213680110</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-5384-9006</orcidid><orcidid>https://orcid.org/0000-0003-2639-3271</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 2013-01, Vol.110 (1), p.348-353
issn 0027-8424
1091-6490
language eng
recordid cdi_pubmed_primary_23248270
source Jstor Complete Legacy; MEDLINE; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects adults
agonists
animal injuries
Animals
behavior disorders
Behavioral neuroscience
Biological Sciences
Blotting, Western
Bridged Bicyclo Compounds - pharmacology
Cell membranes
Chlorides
Chlorides - metabolism
gamma-aminobutyric acid
Gene expression
Gene Expression Regulation - drug effects
H-Reflex
Homeostasis
Immunohistochemistry
Inhibitory Postsynaptic Potentials - physiology
K Cl- Cotransporters
Life Sciences
methylamine
Methylamines - pharmacology
motor neurons
Motor Neurons - metabolism
Muscle Spasticity - drug therapy
Muscle Spasticity - etiology
nervous system diseases
Neurobiology
Neurochemistry
Neurological disorders
Neurons
Neurons and Cognition
Pain
pathogenesis
Pathology
potassium chloride
Proteins
Rats
Receptor, Serotonin, 5-HT2A - metabolism
Receptors
Serotonin
Serotonin - metabolism
Serotonin - pharmacology
Serotonin 5-HT2 Receptor Agonists - pharmacology
Serotonin receptors
Spinal cord
Spinal Cord Injuries - complications
Spinal Nerve roots
symporters
Symporters - metabolism
title Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T10%3A06%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%205-HT2A%20receptors%20upregulates%20the%20function%20of%20the%20neuronal%20K-Cl%20cotransporter%20KCC2&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Bos,%20R%C3%A9mi&rft.date=2013-01-02&rft.volume=110&rft.issue=1&rft.spage=348&rft.epage=353&rft.pages=348-353&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.1213680110&rft_dat=%3Cjstor_pubme%3E42553943%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1266434074&rft_id=info:pmid/23248270&rft_jstor_id=42553943&rfr_iscdi=true